Background
Pentraxin 3 (PTX3) is a novel candidate immunoinflammatory marker that has been reported to be associated with cardiometabolic risk factors and to predict adverse outcomes in patients with coronary artery disease (CAD). Therefore, we assessed the associations among plasma levels of PTX3, high-sensitive C-reactive protein (hsCRP), the lipid profile, and coronary plaques assessed by integrated backscatter intravascular ultrasound (IB-IVUS).
Methods
One hundred seventeen consecutive patients with stable CAD who underwent percutaneous coronary intervention were enrolled. Nonculprit coronary lesions with mild to moderate stenosis were measured by IB-IVUS using 40-MHz intravascular catheter. A total of 20 IB-IVUS images were recorded at an interval of 0.5 mm for 10 mm length in each plaque.
Methods
One hundred seventeen consecutive patients with stable CAD who underwent percutaneous coronary intervention were enrolled. Nonculprit coronary lesions with mild to moderate stenosis were measured by IB-IVUS using 40-MHz intravascular catheter. A total of 20 IB-IVUS images were recorded at an interval of 0.5 mm for 10 mm length in each plaque.
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree
